NCT05950282View on ClinicalTrials.gov

Fasting Insulin and HOMA-IR by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

December 31, 2026

Conditions
Insulin ResistancePolycystic Ovary SyndromeHyperinsulinismObesityMetabolic Syndrome
Trial Locations (1)

77554

RECRUITING

Lilli Health, Houston

Sponsors

Lead Sponsor

Lilli Health
All Listed Sponsors
lead

Lilli Health

OTHER

NCT05950282 - Fasting Insulin and HOMA-IR by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis | Biotech Hunter | Biotech Hunter